News Release
Third quarter 2025 net income (loss) from continuing operations was
Third Quarter Financial Results Highlights
-
Earnings before interest, taxes, depreciation and amortization (“EBITDA”) from ongoing operations for
Aluminum Extrusions was$16.8 million in the third quarter of 2025 versus$6.2 million in the third quarter of 2024 and versus$9.3 million in the second quarter of 2025.- Sales volume was 41.3 million pounds in the third quarter of 2025 versus 34.6 million pounds in the third quarter of 2024 and 40.7 million pounds in the second quarter of 2025.
- Net new orders decreased 5% in the third quarter of 2025 versus the third quarter of 2024 and 16% versus the second quarter of 2025. Open orders at the end of the third quarter of 2025 were 19 million pounds versus 16 million pounds at the end of the third quarter of 2024 and 25 million pounds at the end of the second quarter of 2025.
-
EBITDA from ongoing operations for
PE Films was$7.2 million in the third quarter of 2025 versus$5.9 million in the third quarter of 2024 and versus$6.7 million in the second quarter of 2025.- Sales volume was 9.7 million pounds in the third quarter of 2025 versus 9.6 million pounds in the third quarter of 2024 and 9.8 million pounds in the second quarter of 2025.
OPERATIONS REVIEW
|
|
|
Three Months Ended |
|
Favorable/ |
|
Nine Months Ended |
|
Favorable/ |
||||||||||||||
|
(In thousands, except percentages) |
|
|
|
(Unfavorable) |
|
|
|
(Unfavorable) |
||||||||||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
% Change |
|
|
2025 |
|
|
|
2024 |
|
|
% Change |
|||
|
Sales volume (lbs) |
|
|
41,303 |
|
|
|
34,556 |
|
|
19.5 |
% |
|
|
119,911 |
|
|
|
103,303 |
|
|
16.1 |
% |
|
Net sales |
|
$ |
162,470 |
|
|
$ |
115,717 |
|
|
40.4 |
% |
|
$ |
444,470 |
|
|
$ |
349,353 |
|
|
27.2 |
% |
|
Variable costs |
|
|
124,462 |
|
|
|
90,397 |
|
|
(37.7 |
)% |
|
|
344,043 |
|
|
|
263,007 |
|
|
(30.8 |
)% |
|
Manufacturing fixed costs1 |
|
|
11,906 |
|
|
|
10,218 |
|
|
(16.5 |
)% |
|
|
34,879 |
|
|
|
29,726 |
|
|
(17.3 |
)% |
|
Selling, general and administrative costs1 |
|
|
8,948 |
|
|
|
8,549 |
|
|
(4.7 |
)% |
|
|
28,489 |
|
|
|
24,319 |
|
|
(17.1 |
)% |
|
Other2 |
|
|
346 |
|
|
|
376 |
|
|
8.0 |
% |
|
|
1,808 |
|
|
|
677 |
|
|
(167.1 |
)% |
|
EBITDA from ongoing operations |
|
$ |
16,808 |
|
|
$ |
6,177 |
|
|
172.1 |
% |
|
$ |
35,251 |
|
|
$ |
31,624 |
|
|
11.5 |
% |
|
Depreciation & amortization |
|
|
(4,190 |
) |
|
|
(4,404 |
) |
|
4.9 |
% |
|
|
(12,509 |
) |
|
|
(13,392 |
) |
|
6.6 |
% |
|
EBIT from ongoing operations3 |
|
$ |
12,618 |
|
|
$ |
1,773 |
|
|
611.7 |
% |
|
$ |
22,742 |
|
|
$ |
18,232 |
|
|
24.7 |
% |
|
Capital expenditures |
|
$ |
3,079 |
|
|
$ |
1,449 |
|
|
|
|
$ |
7,835 |
|
|
$ |
4,461 |
|
|
|
||
|
1. Excludes related depreciation and amortization. |
||||||||||||||||||||||
|
2. Includes segment allocated employee compensation benefit expenses. |
||||||||||||||||||||||
|
3. For a reconciliation of this non-GAAP measure to the most directly comparable measure calculated in accordance with GAAP, see the EBITDA from ongoing operations by segment statements in the Financial Tables in this press release. |
||||||||||||||||||||||
The following table presents the sales volume by end use market for the three and nine months ended
|
|
|
Three Months Ended |
|
Favorable/ |
|
Three Months Ended |
|
Favorable/ |
|
Nine Months Ended |
|
Favorable/ |
|||||||
|
(In millions of lbs) |
|
|
|
(Unfavorable) |
|
|
|
(Unfavorable) |
|
|
|
(Unfavorable) |
|||||||
|
|
2025 |
|
2024 |
|
% Change |
|
2025 |
|
% Change |
|
2025 |
|
2024 |
|
% Change |
||||
|
Sales volume by end-use market: |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Non-residential B&C |
|
22.3 |
|
18.7 |
|
19.3 |
% |
|
22.5 |
|
(0.9 |
)% |
|
64.1 |
|
59.1 |
|
8.5 |
% |
|
Residential B&C |
|
2.3 |
|
2.4 |
|
(4.2 |
)% |
|
2.3 |
|
— |
% |
|
6.5 |
|
6.2 |
|
4.8 |
% |
|
Automotive |
|
2.9 |
|
3.2 |
|
(9.4 |
)% |
|
3.2 |
|
(9.4 |
)% |
|
9.2 |
|
9.3 |
|
(1.1 |
)% |
|
Specialty products |
|
13.8 |
|
10.3 |
|
34.0 |
% |
|
12.7 |
|
8.7 |
% |
|
40.1 |
|
28.7 |
|
39.7 |
% |
|
Total |
|
41.3 |
|
34.6 |
|
19.5 |
% |
|
40.7 |
|
1.5 |
% |
|
119.9 |
|
103.3 |
|
16.1 |
% |
Third Quarter 2025 Results vs. Third Quarter 2024 Results
Net sales (sales less freight) in the third quarter of 2025 increased 40.4% versus the third quarter of 2024 primarily due to higher sales volume and the pass-through of higher metal costs. Sales volume in the third quarter of 2025 increased 19.5% versus the third quarter of 2024 and 1.5% versus the second quarter of 2025. The Company increased shipments for curtainwall, storefront and institutional walkway covers within the nonresidential B&C market versus the third quarter of 2024. Within the specialty market, shipments for solar panel products within the electrical product group, machinery and equipment, consumer durables and distribution products increased versus the third quarter of last year. The Company attributes the increase in nonresidential B&C and consumer durables to a pull-forward of demand earlier in the year as customers placed orders in anticipation of higher tariff-related pricing (see discussion on net new orders below).
Year-over-year growth in shipments for TSLOTSTM aluminum framing systems was primarily associated with increased demand for infrastructure associated with data containment and data centers. The Company believes that the growth in the solar and distribution markets was partly due to regaining market share previously lost to imported aluminum extrusions.
Net new orders in the third quarter of 2025 decreased 5% versus the third quarter of 2024 and 16% versus the second quarter of 2025. The decrease in net new orders in the third quarter of 2025, which is largely attributed to the tariff increase to 50%, marked the second quarterly decline for this metric, following 10 consecutive quarterly increases.
Open orders at the end of the third quarter of 2025 were 19 million pounds versus 16 million pounds at the end of the third quarter of 2024 and 25 million pounds at the end of the second quarter of 2025. This level falls below the quarterly range of 21 to 27 million pounds in 2019 before pandemic-related disruptions that resulted in long lead times.
Effective
The trend of net new orders declined after the most recent tariff increase to 50% from an average of 3.4 million pounds per week for the weekly periods ending from
EBITDA from ongoing operations in the third quarter of 2025 increased
-
A
$12.7 million increase in contribution margin (net sales less variable costs) associated with:-
Higher volume (
$4.9 million ), favorable pricing ($4.2 million ) and lower manufacturing costs associated with material yield ($0.5 million favorable in the third quarter of 2025 versus$0.8 million unfavorable in the third quarter of 2024), partially offset by higher labor rates ($0.9 million ), unfavorable labor productivity associated with onboarding new employees ($0.7 million ), higher maintenance and supply expense, partially due to the impact of tariffs ($0.5 million ), and higher utilities ($0.3 million ). -
The timing of the flow-through under the first-in first-out (“FIFO”) method of aluminum raw materials costs, which were previously acquired in a quickly changing commodity pricing environment, causing a temporary mismatch in the change in the cost of raw materials included in variable costs and the pass through to customers included in sales, resulted in a benefit of
$4.3 million in the third quarter of 2025 versus a charge of$1.0 million in the third quarter of 2024.-
The underlying average
U.S. Midwest transaction prices for aluminum (which includes tariffs and duties) and the main factor causing the flow-through timing issue for the related periods compared, were$1.89 and$1.49 per pound in August and May of 2025, and$1.25 and$1.36 per pound in August and May of 2024. The averageU.S. Midwest transaction prices for aluminum for the third and second quarters of 2025 and third and second quarters of 2024 were$1.90 ,$1.56 ,$1.27 and$1.34 per pound, respectively.
-
The underlying average
-
Higher volume (
-
Higher fixed costs primarily associated with wage increases and compensation-related costs (
$0.6 million ), higher maintenance and utilities expenses ($0.5 million ) and added resources to support increasing volume ($0.3 million ). -
Higher selling, general and administrative ("SG&A") expenses primarily associated with employee-related compensation (
$0.4 million ).
First Nine Months of 2025 Results vs. First Nine Months of 2024 Results
Net sales in the first nine months of 2025 increased 27.2% versus the first nine months of 2024 primarily due to higher sales volume and the pass-through of higher metal costs. Sales volume in the first nine months of 2025 increased 16.1% versus the first nine months of 2024.
EBITDA from ongoing operations in the first nine months of 2025 increased
-
A
$14.0 million increase in contribution margin associated with:-
Higher volume and favorable mix (
$15.6 million ), partially offset by higher variable manufacturing costs associated with material yield in the first five months of 2025, which was unfavorable to projected rates ($0.8 million unfavorable in the first nine months of 2025 versus$0.2 million unfavorable in the first nine months of 2024), higher labor rates ($2.3 million ), decreased labor productivity associated with onboarding new employees ($1.2 million ), higher maintenance expense, primarily associated with downed equipment, extreme winter weather events in the first quarter of 2025 and tariff impacts ($1.0 million ), higher die expense associated with the timing of purchases in the first quarter of 2025 ($0.7 million ), higher expense for externally purchased (versus internally produced) billet related to increasing volume ($1.0 million ) and higher utilities ($0.7 million ). -
The timing of the flow-through under the FIFO method of aluminum raw material costs, which were previously acquired at lower prices in a quickly changing commodity pricing environment and passed through to customers, resulted in a benefit of
$5.4 million in the first nine months of 2025 versus a charge of$1.0 million in the first nine months of 2024.
-
Higher volume and favorable mix (
-
Higher fixed costs associated with wage increases and compensation-related costs (
$2.4 million ), higher maintenance and utilities ($1.2 million ) and added resources to support increasing volume ($0.9 million ). -
Higher SG&A expenses primarily associated with employee-related compensation (
$3.3 million ), increased training and onboarding expense ($0.5 million ) and routine environmental compliance costs ($0.3 million ). -
Higher other expense for employee-related medical costs caused by an increase in the number of high-cost medical claims versus favorable experience in recent years (
$1.1 million ). The Company is self-insured for medical claims with stop loss coverage for claims of over$0.3 million .
Manufacturing costs versus expectations during the second quarter of 2025 were unfavorable by approximately
Refer to Item 3. Quantitative and Qualitative Disclosures About Market Risk in the Company’s Quarterly Report on Form 10-Q for the period ended
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
|
|
|
Three Months Ended |
|
Favorable/ |
|
Nine Months Ended |
|
Favorable/ |
||||||||||||||
|
(In thousands, except percentages) |
|
|
|
(Unfavorable) |
|
|
|
(Unfavorable) |
||||||||||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
% Change |
|
|
2025 |
|
|
|
2024 |
|
|
% Change |
|||
|
Sales volume (lbs) |
|
|
9,656 |
|
|
|
9,640 |
|
|
0.2 |
% |
|
|
29,093 |
|
|
|
30,223 |
|
|
(3.7 |
)% |
|
Net sales |
|
$ |
25,883 |
|
|
$ |
24,879 |
|
|
4.0 |
% |
|
$ |
76,017 |
|
|
$ |
78,811 |
|
|
(3.5 |
)% |
|
Variable costs |
|
|
11,922 |
|
|
|
12,294 |
|
|
3.0 |
% |
|
|
35,586 |
|
|
|
37,522 |
|
|
5.2 |
% |
|
Manufacturing fixed costs1 |
|
|
3,785 |
|
|
|
3,496 |
|
|
(8.3 |
)% |
|
|
10,487 |
|
|
|
9,832 |
|
|
(6.7 |
)% |
|
Selling, general and administrative costs1 |
|
|
2,961 |
|
|
|
3,173 |
|
|
6.7 |
% |
|
|
8,420 |
|
|
|
8,480 |
|
|
0.7 |
% |
|
Other2 |
|
|
(6 |
) |
|
|
40 |
|
|
115.0 |
% |
|
|
70 |
|
|
|
64 |
|
|
(9.4 |
)% |
|
EBITDA from ongoing operations |
|
$ |
7,221 |
|
|
$ |
5,876 |
|
|
22.9 |
% |
|
$ |
21,454 |
|
|
$ |
22,913 |
|
|
(6.4 |
)% |
|
Depreciation & amortization |
|
|
(1,224 |
) |
|
|
(1,299 |
) |
|
5.8 |
% |
|
|
(3,705 |
) |
|
|
(3,944 |
) |
|
6.1 |
% |
|
EBIT from ongoing operations3 |
|
$ |
5,997 |
|
|
$ |
4,577 |
|
|
31.0 |
% |
|
$ |
17,749 |
|
|
$ |
18,969 |
|
|
(6.4 |
)% |
|
Capital expenditures |
|
$ |
529 |
|
|
$ |
517 |
|
|
|
|
$ |
1,411 |
|
|
$ |
1,127 |
|
|
|
||
|
1. Excludes related depreciation and amortization. |
||||||||||||||||||||||
|
2. Includes segment allocated employee compensation benefit expenses. |
||||||||||||||||||||||
|
3. For a reconciliation of this non-GAAP measure to the most directly comparable measure calculated in accordance with GAAP, see the EBITDA from ongoing operations by segment statements in the Financial Tables in this press release. |
||||||||||||||||||||||
Third Quarter 2025 Results vs. Third Quarter 2024 Results
Net sales in the third quarter of 2025 increased 4.0% versus the third quarter of 2024 due to an increase in sales volume in surface protection films. Sales volume increased 10.9% in surface protection films versus the third quarter of 2024 and 16.1% versus the second quarter of 2025. Recent volume performance for Surface Protection is expected to moderate for the remainder of the year. Volume for overwrap films, which are predominantly manufactured and sold in the
To date, Surface Protection has not experienced an adverse impact on customer demand related to tariff actions; however, the situation remains fluid and the impact on consumer electronics is uncertain.
EBITDA from ongoing operations in the third quarter of 2025 increased
-
An increase in contribution margin of
$1.4 million resulting from:-
A
$1.8 million increase from Surface Protection associated with higher volume ($0.7 million ), cost improvements and favorable productivity ($1.0 million ) and the pass-through lag associated with resin costs (a charge of$0.1 million in the third quarter of 2025 versus a charge of$0.2 million in the third quarter of 2024). -
A
$0.4 million decrease from overwrap films primarily due to lower volume ($0.1 million ) and unfavorable productivity ($0.3 million )
-
A
There have been significant cyclical swings in the sales volume and EBITDA from ongoing operations for
First Nine Months of 2025 Results vs. First Nine Months of 2024 Results
Net sales in the first nine months of 2025 decreased 3.5% compared to the first nine months of 2024 due to a decrease in sales volume in Surface Protection and overwrap films. Sales volume decreased 1.9% in Surface Protection in the first nine months of 2025 versus the first nine months of 2024. Sales volume for overwrap films decreased 5.7% in the first nine months of 2025 versus the first nine months of 2024.
EBITDA from ongoing operations in the first nine months of 2025 decreased
-
A decrease in contribution margin of
$0.8 million resulting from:-
Flat contribution margin in Surface Protection associated with lower volume (
$3.2 million ) offset by cost improvements and favorable pricing ($2.7 million ) and the pass-through lag associated with resin costs (a charge of$0.2 million in the first nine months of 2025 versus a charge of$0.7 million in the first nine months of 2024). -
A
$0.8 million decrease in overwrap films primarily due to lower volume, unfavorable mix and pricing ($0.9 million ) and unfavorable productivity ($0.3 million ), partially offset by cost improvements ($0.2 million ) and the pass-through lag associated with resin costs (a charge of$0.1 million in the first nine months of 2025 versus a charge of$0.3 million in the first nine months of 2024).
-
Flat contribution margin in Surface Protection associated with lower volume (
-
Higher fixed costs primarily associated with wage increases and compensation-related costs (
$0.4 million ).
Refer to Item 3. Quantitative and Qualitative Disclosures About Market Risk in the Third Quarter Form 10-Q for additional information on resin price trends.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for
Corporate Expenses, Interest, Taxes and Other
Corporate expenses, net in the first nine months of 2025 increased
Interest expense was
The effective tax rate used to compute income taxes (benefit) from continuing operations in the first nine months of 2025 was 27.1% compared to 27.5% in the first nine months of 2024. The effective tax rate in the first nine months of 2025 and the first nine months of 2024 was impacted by taxable discrete items, including stock-based compensation. See Note (d) to Financial Tables in this Press Release for information related to the effective tax rate from ongoing operations. Refer to Note 8 to the Company’s Condensed Consolidated Financial Statements in the Third Quarter Form 10-Q for an explanation of differences between the effective tax rate for income (loss) from continuing operations and the
Debt, Financial Leverage, Debt Covenants and Debt Refinancing
Total debt was
Total debt decreased
As of
FORWARD-LOOKING AND CAUTIONARY STATEMENTS
Some of the information contained in this press release may constitute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When the Company uses the words “believe,” “estimate,” “anticipate,” “appear to,” “expect,” “project,” “plan,” “likely,” “may” and similar expressions, it does so to identify forward-looking statements. Such statements are based on the Company's then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. Factors that could cause actual results to differ materially from expectations include, without limitation, the following:
- the impact of macroeconomic factors, such as inflation, interest rates and recession risks;
- an increase in the operating costs incurred by the Company’s business units, including, for example, the cost of raw materials and energy;
- noncompliance with any of the financial and other restrictive covenants in the ABL Facility;
- failure to continue to attract, develop and retain certain key officers or employees;
- disruptions to the Company’s manufacturing facilities, including those resulting from labor shortages;
- an information technology system failure or breach;
-
risks of doing business in countries outside the
U.S. that affect our international operations; - the impact of public health epidemics on employees, production and the global economy, such as the COVID-19 pandemic;
- political, economic and regulatory factors concerning the Company’s products;
- inability to develop, efficiently manufacture and deliver new products at competitive prices;
-
the impact of the imposition of tariffs and sanctions on imported aluminum ingot used by
Bonnell Aluminum ; - failure by governmental entities to prevent foreign companies from evading antidumping and countervailing duties;
- unanticipated problems or delays with the implementation of the enterprise resource planning and manufacturing executions systems, or security breaches and other disruptions to the Company's information technology infrastructure;
- loss of sales to significant customers on which the Company’s business is highly dependent;
- inability to achieve sales to new customers to replace lost business;
- failure of the Company’s customers to achieve success or maintain market share;
- failure to protect our intellectual property rights;
- inability to successfully complete strategic acquisitions or dispositions, failure to realize the expected benefits of such acquisitions or dispositions, and assumption of unanticipated risks in such acquisitions or dispositions;
and the other factors discussed in the reports Tredegar files with or furnishes to
Tredegar does not undertake, and expressly disclaims any duty, to update any forward-looking statement made in this press release to reflect any change in management’s expectations or any change in conditions, assumptions or circumstances on which such statements are based, except as required by applicable law.
To the extent that the financial information portion of this press release contains non-GAAP financial measures, it also presents both the most directly comparable financial measures calculated and presented in accordance with GAAP and a quantitative reconciliation of the difference between any such non-GAAP measures and such comparable GAAP financial measures. Reconciliations of non-GAAP financial measures are provided in the Notes to the Financial Tables included with this press release and can also be found within “Presentations” in the “Investors” section of our website, www.tredegar.com.
Tredegar uses its website as a channel of distribution of material company information. Financial information and other material information regarding Tredegar is posted on and assembled in the “Investors” section of its website.
|
|
|||||||||||||||
|
Condensed Consolidated Statements of Income |
|||||||||||||||
|
(In Thousands, Except Per-Share Data) |
|||||||||||||||
|
(Unaudited) |
|||||||||||||||
|
|
|
|
|
|
|||||||||||
|
|
|
Three Months Ended |
|
Nine Months Ended |
|||||||||||
|
|
|
|
|
|
|||||||||||
|
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
2024 |
|
|
Sales |
|
$ |
194,942 |
|
|
$ |
146,064 |
|
|
$ |
538,796 |
|
$ |
443,976 |
|
|
Other income (expense), net (c) |
|
|
4 |
|
|
|
(26 |
) |
|
|
1,381 |
|
|
304 |
|
|
|
|
|
194,946 |
|
|
|
146,038 |
|
|
|
540,177 |
|
|
444,280 |
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Cost of goods sold (c) |
|
|
157,209 |
|
|
|
122,471 |
|
|
|
441,387 |
|
|
356,591 |
|
|
Freight |
|
|
6,589 |
|
|
|
5,468 |
|
|
|
18,309 |
|
|
15,812 |
|
|
Selling, R&D and general expenses (c) |
|
|
20,372 |
|
|
|
18,974 |
|
|
|
61,947 |
|
|
54,713 |
|
|
Amortization of identifiable intangibles |
|
|
440 |
|
|
|
440 |
|
|
|
1,319 |
|
|
1,339 |
|
|
Pension and postretirement benefits |
|
|
27 |
|
|
|
54 |
|
|
|
30 |
|
|
163 |
|
|
Interest expense |
|
|
768 |
|
|
|
1,192 |
|
|
|
3,566 |
|
|
3,515 |
|
|
Asset impairments and costs associated with exit and disposal activities, net of adjustments (c) |
|
|
418 |
|
|
|
— |
|
|
|
435 |
|
|
587 |
|
|
|
|
|
185,823 |
|
|
|
148,599 |
|
|
|
526,993 |
|
|
432,720 |
|
|
Income (loss) from continuing operations before income taxes |
|
|
9,123 |
|
|
|
(2,561 |
) |
|
|
13,184 |
|
|
11,560 |
|
|
Income tax expense (benefit) |
|
|
2,014 |
|
|
|
828 |
|
|
|
3,575 |
|
|
3,175 |
|
|
Net income (loss) from continuing operations |
|
|
7,109 |
|
|
|
(3,389 |
) |
|
|
9,609 |
|
|
8,385 |
|
|
Income (loss) from discontinued operations, net of tax |
|
|
(35 |
) |
|
|
(557 |
) |
|
|
9,297 |
|
|
(251 |
) |
|
Net income (loss) |
|
$ |
7,074 |
|
|
$ |
(3,946 |
) |
|
$ |
18,906 |
|
$ |
8,134 |
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Earnings (loss) per share: |
|
|
|
|
|
|
|
|
|||||||
|
Basic: |
|
|
|
|
|
|
|
|
|||||||
|
Continuing operations |
|
$ |
0.20 |
|
|
$ |
(0.10 |
) |
|
$ |
0.28 |
|
$ |
0.24 |
|
|
Discontinued operations |
|
|
— |
|
|
|
(0.01 |
) |
|
|
0.27 |
|
|
— |
|
|
Basic earnings (loss) per share |
|
$ |
0.20 |
|
|
$ |
(0.11 |
) |
|
$ |
0.55 |
|
$ |
0.24 |
|
|
Diluted: |
|
|
|
|
|
|
|
|
|||||||
|
Continuing operations |
|
$ |
0.20 |
|
|
$ |
(0.10 |
) |
|
$ |
0.28 |
|
$ |
0.24 |
|
|
Discontinued operations |
|
|
— |
|
|
|
(0.01 |
) |
|
|
0.27 |
|
|
— |
|
|
Diluted earnings (loss) per share |
|
$ |
0.20 |
|
|
$ |
(0.11 |
) |
|
$ |
0.55 |
|
$ |
0.24 |
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Shares used to compute earnings (loss) per share: |
|
|
|
|
|
|
|
|
|||||||
|
Basic |
|
|
34,773 |
|
|
|
34,391 |
|
|
|
34,721 |
|
|
34,364 |
|
|
Diluted |
|
|
34,773 |
|
|
|
34,391 |
|
|
|
34,721 |
|
|
34,364 |
|
|
|
||||||||||||||||
|
|
||||||||||||||||
|
(In Thousands) |
||||||||||||||||
|
(Unaudited) |
||||||||||||||||
|
|
|
|
|
|
||||||||||||
|
|
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
|
|
|
|
|
||||||||||||
|
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
$ |
162,470 |
|
|
$ |
115,717 |
|
|
$ |
444,470 |
|
|
$ |
349,353 |
|
|
|
|
|
25,883 |
|
|
|
24,879 |
|
|
|
76,017 |
|
|
|
78,811 |
|
|
Total net sales |
|
|
188,353 |
|
|
|
140,596 |
|
|
|
520,487 |
|
|
|
428,164 |
|
|
Add back freight |
|
|
6,589 |
|
|
|
5,468 |
|
|
|
18,309 |
|
|
|
15,812 |
|
|
Sales as shown in the condensed consolidated statements of income |
|
$ |
194,942 |
|
|
$ |
146,064 |
|
|
$ |
538,796 |
|
|
$ |
443,976 |
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
EBITDA from Ongoing Operations (f) |
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
Ongoing operations: |
|
|
|
|
|
|
|
|
||||||||
|
EBITDA (b) |
|
$ |
16,808 |
|
|
$ |
6,177 |
|
|
$ |
35,251 |
|
|
$ |
31,624 |
|
|
Depreciation & amortization |
|
|
(4,190 |
) |
|
|
(4,404 |
) |
|
|
(12,509 |
) |
|
|
(13,392 |
) |
|
EBIT (b) |
|
|
12,618 |
|
|
|
1,773 |
|
|
|
22,742 |
|
|
|
18,232 |
|
|
Plant shutdowns, asset impairments, restructurings and other (c) |
|
|
(927 |
) |
|
|
(2,170 |
) |
|
|
(2,151 |
) |
|
|
(4,986 |
) |
|
|
|
|
|
|
|
|
|
|
||||||||
|
Ongoing operations: |
|
|
|
|
|
|
|
|
||||||||
|
EBITDA (b) |
|
$ |
7,221 |
|
|
$ |
5,876 |
|
|
$ |
21,454 |
|
|
$ |
22,913 |
|
|
Depreciation & amortization |
|
|
(1,224 |
) |
|
|
(1,299 |
) |
|
|
(3,705 |
) |
|
|
(3,944 |
) |
|
EBIT (b) |
|
|
5,997 |
|
|
|
4,577 |
|
|
|
17,749 |
|
|
|
18,969 |
|
|
Plant shutdowns, asset impairments, restructurings and other (c) |
|
|
12 |
|
|
|
— |
|
|
|
13 |
|
|
|
(584 |
) |
|
Total |
|
|
17,700 |
|
|
|
4,180 |
|
|
|
38,353 |
|
|
|
31,631 |
|
|
Interest income |
|
|
6 |
|
|
|
5 |
|
|
|
16 |
|
|
|
30 |
|
|
Interest expense |
|
|
768 |
|
|
|
1,192 |
|
|
|
3,566 |
|
|
|
3,515 |
|
|
Gain on investment in kaleo, Inc. |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
144 |
|
|
Corporate expenses, net (c) |
|
|
7,815 |
|
|
|
5,554 |
|
|
|
21,619 |
|
|
|
16,730 |
|
|
Income (loss) from continuing operations before income taxes |
|
|
9,123 |
|
|
|
(2,561 |
) |
|
|
13,184 |
|
|
|
11,560 |
|
|
Income tax expense (benefit) |
|
|
2,014 |
|
|
|
828 |
|
|
|
3,575 |
|
|
|
3,175 |
|
|
Net income (loss) from continuing operations |
|
|
7,109 |
|
|
|
(3,389 |
) |
|
|
9,609 |
|
|
|
8,385 |
|
|
Income (loss) from discontinued operations, net of tax |
|
|
(35 |
) |
|
|
(557 |
) |
|
|
9,297 |
|
|
|
(251 |
) |
|
Net income (loss) |
|
$ |
7,074 |
|
|
$ |
(3,946 |
) |
|
$ |
18,906 |
|
|
$ |
8,134 |
|
|
|
||||||
|
Condensed Consolidated Balance Sheets |
||||||
|
(In Thousands) |
||||||
|
(Unaudited) |
||||||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
Assets |
|
|
|
|
||
|
Cash & cash equivalents |
|
$ |
13,291 |
|
$ |
7,062 |
|
Accounts & other receivables, net |
|
|
87,931 |
|
|
64,817 |
|
Income taxes recoverable |
|
|
284 |
|
|
— |
|
Inventories |
|
|
62,006 |
|
|
51,381 |
|
Prepaid expenses & other |
|
|
11,375 |
|
|
16,567 |
|
Total current assets |
|
|
174,887 |
|
|
139,827 |
|
Property, plant & equipment, net |
|
|
130,397 |
|
|
137,032 |
|
Right-of-use leased assets |
|
|
13,267 |
|
|
14,635 |
|
Identifiable intangible assets, net |
|
|
6,008 |
|
|
7,326 |
|
|
|
|
22,446 |
|
|
22,446 |
|
Deferred income taxes |
|
|
29,671 |
|
|
32,517 |
|
Other assets |
|
|
2,130 |
|
|
2,448 |
|
Non-current assets of discontinued operations |
|
|
— |
|
|
126 |
|
Total assets |
|
$ |
378,806 |
|
$ |
356,357 |
|
Liabilities and Shareholders’ Equity |
|
|
|
|
||
|
Accounts payable |
|
$ |
79,247 |
|
$ |
64,704 |
|
Accrued expenses |
|
|
22,801 |
|
|
22,168 |
|
Lease liability, short-term |
|
|
2,345 |
|
|
2,453 |
|
Short-term debt |
|
|
— |
|
|
1,322 |
|
Income taxes payable |
|
|
492 |
|
|
320 |
|
Current liabilities of discontinued operations |
|
|
— |
|
|
741 |
|
Total current liabilities |
|
|
104,885 |
|
|
91,708 |
|
Lease liability, long-term |
|
|
11,472 |
|
|
12,993 |
|
ABL revolving facility |
|
|
49,500 |
|
|
60,600 |
|
Pension and other postretirement benefit obligations, net |
|
|
5,772 |
|
|
5,914 |
|
Deferred income taxes |
|
|
69 |
|
|
69 |
|
Other non-current liabilities |
|
|
4,917 |
|
|
4,105 |
|
Shareholders’ equity |
|
|
202,191 |
|
|
180,968 |
|
Total liabilities and shareholders’ equity |
|
$ |
378,806 |
|
$ |
356,357 |
|
|
||||||||
|
Condensed Consolidated Statements of Cash Flows |
||||||||
|
(In Thousands) |
||||||||
|
(Unaudited) |
||||||||
|
|
|
|
||||||
|
|
|
Nine Months Ended
|
||||||
|
|
|
|
2025 |
|
|
|
2024 |
|
|
Cash flows from operating activities: |
|
|
|
|
||||
|
Net income (loss) |
|
$ |
18,906 |
|
|
$ |
8,134 |
|
|
Adjustments for noncash items: |
|
|
|
|
||||
|
Depreciation |
|
|
15,041 |
|
|
|
18,372 |
|
|
Amortization of intangibles |
|
|
1,319 |
|
|
|
1,410 |
|
|
Reduction of right-of-use assets |
|
|
1,584 |
|
|
|
1,735 |
|
|
Deferred income taxes |
|
|
2,873 |
|
|
|
2,975 |
|
|
Accrued pension and postretirement benefits |
|
|
134 |
|
|
|
163 |
|
|
Stock-based compensation expense |
|
|
1,759 |
|
|
|
1,950 |
|
|
Gain on investment in kaléo |
|
|
— |
|
|
|
(144 |
) |
|
Gain on the sale of assets |
|
|
(1,497 |
) |
|
|
— |
|
|
Gain on sale of divested business |
|
|
(9,657 |
) |
|
|
— |
|
|
Changes in assets and liabilities: |
|
|
|
|
||||
|
Accounts and other receivables |
|
|
(23,113 |
) |
|
|
(14,683 |
) |
|
Inventories |
|
|
(10,615 |
) |
|
|
(8,711 |
) |
|
Income taxes recoverable/payable |
|
|
(111 |
) |
|
|
(952 |
) |
|
Prepaid expenses and other |
|
|
5,909 |
|
|
|
(286 |
) |
|
Accounts payable and accrued expenses |
|
|
14,407 |
|
|
|
(3,454 |
) |
|
Lease liability |
|
|
(1,800 |
) |
|
|
(2,118 |
) |
|
Pension and postretirement benefit plan contributions |
|
|
(430 |
) |
|
|
(455 |
) |
|
Other, net |
|
|
2,559 |
|
|
|
2,117 |
|
|
Net cash provided by (used in) operating activities |
|
|
17,268 |
|
|
|
6,053 |
|
|
Cash flows from investing activities: |
|
|
|
|
||||
|
Capital expenditures |
|
|
(9,246 |
) |
|
|
(7,696 |
) |
|
Proceeds from the sale of Terphane |
|
|
9,835 |
|
|
|
— |
|
|
Proceeds on sale of investment in kaléo |
|
|
— |
|
|
|
144 |
|
|
Proceeds from the sale of assets |
|
|
1,904 |
|
|
|
83 |
|
|
Net cash provided by (used in) investing activities |
|
|
2,493 |
|
|
|
(7,469 |
) |
|
Cash flows from financing activities: |
|
|
|
|
||||
|
Borrowings |
|
|
103,747 |
|
|
|
519,274 |
|
|
Debt principal payments |
|
|
(116,173 |
) |
|
|
(522,240 |
) |
|
Debt financing costs |
|
|
(1,272 |
) |
|
|
(587 |
) |
|
Net cash provided by (used in) financing activities |
|
|
(13,698 |
) |
|
|
(3,553 |
) |
|
Effect of exchange rate changes on cash |
|
|
166 |
|
|
|
(1,898 |
) |
|
Increase (decrease) in cash and cash equivalents |
|
|
6,229 |
|
|
|
(6,867 |
) |
|
Cash and cash equivalents at beginning of period |
|
|
7,062 |
|
|
|
13,455 |
|
|
Cash and cash equivalents at end of period |
|
$ |
13,291 |
|
|
$ |
6,588 |
|
Notes to the Financial Tables
(Unaudited)
|
(a) |
Tredegar’s presentation of net income (loss) and diluted earnings (loss) per share from ongoing operations are non-GAAP financial measures that exclude the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, discontinued operations, net periodic benefit cost for the frozen defined benefit pension plan prior to termination and other items (which includes gains and losses for an investment accounted for under the fair value method) which have been presented separately and removed from net income (loss) from continuing operations and diluted earnings (loss) per share as reported under GAAP. Net income (loss) and diluted earnings (loss) per share from ongoing operations are key financial and analytical measures used by management to gauge the operating performance of Tredegar’s ongoing operations. They are not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) from continuing operations or earnings (loss) per share as defined by GAAP. They exclude items that management believes do not relate to Tredegar’s ongoing operations. A reconciliation to net income (loss) and diluted earnings (loss) per share from ongoing operations for the three and nine months ended |
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|||||||||
|
(In millions, except per share data) |
|
|
2025 |
|
|
2024 |
|
|
|
2025 |
|
|
2024 |
|
Net income (loss) from continuing operations as reported under GAAP1 |
|
$ |
7.1 |
|
$ |
(3.4 |
) |
|
$ |
9.6 |
|
$ |
8.4 |
|
After-tax effects of: |
|
|
|
|
|
|
|
|
|||||
|
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
|
0.3 |
|
|
— |
|
|
|
0.3 |
|
|
0.5 |
|
(Gains) losses from sale of assets and other: |
|
|
|
|
|
|
|
|
|||||
|
Valuation allowance on existing deferred tax assets as a result of the sale of Terphane |
|
|
— |
|
|
1.8 |
|
|
|
— |
|
|
1.8 |
|
Other |
|
|
1.8 |
|
|
1.8 |
|
|
|
4.7 |
|
|
4.6 |
|
Net income (loss) from ongoing operations1 |
|
$ |
9.2 |
|
$ |
0.2 |
|
|
$ |
14.6 |
|
$ |
15.3 |
|
|
|
|
|
|
|
|
|
|
|||||
|
Earnings (loss) from continuing operations per share as reported under GAAP (diluted) |
|
$ |
0.20 |
|
$ |
(0.10 |
) |
|
$ |
0.28 |
|
$ |
0.24 |
|
After-tax effects per diluted share of: |
|
|
|
|
|
|
|
|
|||||
|
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
|
0.01 |
|
|
— |
|
|
|
0.01 |
|
|
0.01 |
|
(Gains) losses from sale of assets and other: |
|
|
|
|
|
|
|
|
|||||
|
Valuation allowance on existing deferred tax assets as a result of the sale of Terphane |
|
|
— |
|
|
0.05 |
|
|
|
— |
|
|
0.05 |
|
Other |
|
|
0.05 |
|
|
0.06 |
|
|
|
0.12 |
|
|
0.14 |
|
Earnings (loss) per share from ongoing operations (diluted) |
|
$ |
0.26 |
|
$ |
0.01 |
|
|
$ |
0.41 |
|
$ |
0.44 |
|
1. Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) are shown in Note (d). |
|||||||||||||
|
(b) |
EBITDA (earnings before interest, taxes, depreciation and amortization) from ongoing operations is the key segment profitability metric used by the Company’s chief operating decision maker (“CODM”) to assess segment financial performance. The Company uses sales less freight (“net sales”) as its measure of revenues from external customers at the segment level. For more business segment information, see Note 9 to the Company’s Condensed Consolidated Financial Statements in the Third Quarter Form 10-Q. |
||
|
|
EBIT (earnings before interest and taxes) from ongoing operations is a non-GAAP financial measure included in the accompanying tables and the reconciliation of segment financial information to consolidated results for the Company in the net sales and EBITDA from ongoing operations by segment statements. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) as defined by GAAP. The Company believes that EBIT is a widely understood and utilized metric that is meaningful to certain investors and that including this financial metric in the reconciliation of management’s performance metric, EBITDA from ongoing operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company’s core operations. |
||
|
(c) |
Gains and losses associated with plant shutdowns, asset impairments, restructurings and other items for the three and nine months ended |
|
|
Three Months Ended
|
Nine Months Ended
|
||||||||
|
(In millions) |
Pre-Tax |
Net of Tax |
Pre-Tax |
Net of Tax |
||||||
|
|
|
|
|
|
||||||
|
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
||||||
|
Production equipment asset impairment |
$ |
0.4 |
$ |
0.3 |
$ |
0.4 |
|
$ |
0.3 |
|
|
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||
|
Consulting expenses for ERP/MES project1 |
|
0.4 |
|
0.3 |
|
1.2 |
|
|
0.9 |
|
|
Legal fees associated with the Aluminum Extruders Trade Case and other matters1 |
|
— |
|
— |
|
0.1 |
|
|
0.2 |
|
|
Storm damage to the |
|
— |
|
— |
|
(0.2 |
) |
|
(0.1 |
) |
|
Aluminum extrusion press fire at the |
|
0.1 |
|
0.1 |
|
0.1 |
|
|
0.1 |
|
|
Aluminum premium charge as a result of unplanned maintenance interruptions2 |
|
— |
|
— |
|
0.3 |
|
|
0.2 |
|
|
Total for |
$ |
0.9 |
$ |
0.7 |
$ |
1.9 |
|
$ |
1.6 |
|
|
Corporate: |
|
|
|
|
||||||
|
(Gain) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||
|
Professional fees associated with business development activities1 |
$ |
1.8 |
$ |
1.4 |
$ |
5.6 |
|
$ |
4.3 |
|
|
Professional fees associated with remediation activities related to internal control over financial reporting1 |
|
— |
|
— |
|
0.2 |
|
|
0.1 |
|
|
Group annuity contract premium adjustment3 |
|
— |
|
— |
|
0.1 |
|
|
0.1 |
|
|
Professional fees associated with the transition to the ABL Facility1 |
|
— |
|
— |
|
0.2 |
|
|
0.2 |
|
|
Proceeds on the sale of corporate-owned land3 |
|
— |
|
— |
|
(1.5 |
) |
|
(1.2 |
) |
|
Total for Corporate |
$ |
1.8 |
$ |
1.4 |
$ |
4.6 |
|
$ |
3.5 |
|
|
1. Included in “Selling, R&D and general expenses” in the condensed consolidated statements of income. |
||||||||||
|
2. Included in “Cost of Goods Sold” in the condensed consolidated statements of income. |
||||||||||
|
3. Included in “Other income (expense), net” in the condensed consolidated statements of income. |
||||||||||
|
|
Three Months Ended
|
Nine Months Ended
|
||||||||
|
(In millions) |
Pre-Tax |
Net of Tax |
Pre-Tax |
Net of Tax |
||||||
|
|
|
|
|
|
||||||
|
(Gains) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||
|
Consulting expenses for ERP/MES project1 |
$ |
0.7 |
$ |
0.5 |
$ |
2.1 |
|
$ |
1.6 |
|
|
Storm damage to the |
|
— |
|
— |
|
0.3 |
|
|
0.2 |
|
|
Legal fees associated with the Aluminum Extruders Trade Case1 |
|
0.4 |
|
0.3 |
|
0.9 |
|
|
0.7 |
|
|
Resolution of customer quality complaint4 |
|
0.8 |
|
0.6 |
|
0.8 |
|
|
0.6 |
|
|
Total for |
$ |
1.9 |
$ |
1.4 |
$ |
4.1 |
|
$ |
3.1 |
|
|
|
|
|
|
|
||||||
|
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: |
|
|
|
|
||||||
|
|
$ |
— |
$ |
— |
$ |
0.3 |
|
$ |
0.2 |
|
|
|
|
— |
|
— |
|
0.3 |
|
|
0.3 |
|
|
Total for |
$ |
— |
$ |
— |
$ |
0.6 |
|
$ |
0.5 |
|
|
Corporate: |
|
|
|
|
||||||
|
(Gain) losses from sale of assets, investment writedowns and other items: |
|
|
|
|
||||||
|
Professional fees associated with business development activities1 |
$ |
0.1 |
$ |
0.1 |
$ |
0.3 |
|
$ |
0.4 |
|
|
Professional fees associated with remediation activities related to internal control over financial reporting1 |
|
0.3 |
|
0.2 |
|
1.6 |
|
|
1.2 |
|
|
Professional fees associated with the transition to the ABL Facility1 |
|
0.1 |
|
0.1 |
|
0.3 |
|
|
0.2 |
|
|
Valuation allowance on existing deferred tax assets as a result of the sale of Terphane5 |
|
— |
|
1.8 |
|
— |
|
|
1.8 |
|
|
Group annuity contract premium adjustment3 |
|
— |
|
— |
|
(0.2 |
) |
|
(0.2 |
) |
|
Total for Corporate |
$ |
0.5 |
$ |
2.2 |
$ |
2.0 |
|
$ |
3.4 |
|
|
1. Included in “Selling, R&D and general expenses” in the condensed consolidated statements of income. |
||||||||||
|
2. For more information, see Note (g). |
||||||||||
|
3. Included in “Other income (expense), net” in the condensed consolidated statements of income. |
||||||||||
|
4. Included in “Sales” in the condensed consolidated statements of income. |
||||||||||
|
5. Included in “Income tax expense (benefit)” in the condensed consolidated statements of income. |
||||||||||
|
(d) |
For discussion on Tredegar’s presentation of net income (loss) from ongoing operations, please refer to Note (a) above. Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) from ongoing operations for the three and nine months ended |
|
(In millions) |
Pre-Tax |
|
Taxes Expense (Benefit) |
|
After-Tax |
|
Effective Tax Rate |
|||||||
|
Three Months Ended |
(a) |
|
(b) |
|
|
|
(b)/(a) |
|||||||
|
Net income (loss) from continuing operations as reported under GAAP |
$ |
9.1 |
|
|
$ |
2.0 |
|
|
$ |
7.1 |
|
|
22.1 |
% |
|
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
0.4 |
|
|
|
0.1 |
|
|
|
0.3 |
|
|
|
|
|
(Gains) losses from sale of assets and other |
|
2.3 |
|
|
|
0.5 |
|
|
|
1.8 |
|
|
|
|
|
Net income (loss) from ongoing operations |
$ |
11.8 |
|
|
$ |
2.6 |
|
|
$ |
9.2 |
|
|
22.1 |
% |
|
Three Months Ended |
|
|
|
|
|
|
|
|||||||
|
Net income (loss) from continuing operations as reported under GAAP |
$ |
(2.6 |
) |
|
$ |
0.8 |
|
|
$ |
(3.4 |
) |
|
(32.3 |
)% |
|
(Gains) losses from sale of assets and other |
|
2.4 |
|
|
|
(1.2 |
) |
|
|
3.6 |
|
|
|
|
|
Net income (loss) from ongoing operations |
$ |
(0.2 |
) |
|
$ |
(0.4 |
) |
|
$ |
0.2 |
|
|
200.0 |
% |
|
Nine Months Ended |
|
|
|
|
|
|
|
|||||||
|
Net income (loss) from continuing operations as reported under GAAP |
$ |
13.2 |
|
|
$ |
3.6 |
|
|
$ |
9.6 |
|
|
27.1 |
% |
|
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
0.4 |
|
|
|
0.1 |
|
|
|
0.3 |
|
|
|
|
|
(Gains) losses from sale of assets and other |
|
6.1 |
|
|
|
1.4 |
|
|
|
4.7 |
|
|
|
|
|
Net income (loss) from ongoing operations |
$ |
19.7 |
|
|
$ |
5.1 |
|
|
$ |
14.6 |
|
|
25.8 |
% |
|
Nine Months Ended |
|
|
|
|
|
|
|
|||||||
|
Net income (loss) continuing operations as reported under GAAP |
$ |
11.6 |
|
|
$ |
3.2 |
|
|
$ |
8.4 |
|
|
27.5 |
% |
|
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
0.6 |
|
|
|
0.1 |
|
|
|
0.5 |
|
|
|
|
|
(Gains) losses from sale of assets and other |
|
6.0 |
|
|
|
(0.4 |
) |
|
|
6.4 |
|
|
|
|
|
Net income (loss) from ongoing operations |
$ |
18.2 |
|
|
$ |
2.9 |
|
|
$ |
15.3 |
|
|
15.9 |
% |
|
(e) |
Net debt is calculated as follows: |
|
(In millions) |
|
|
|
|
||
|
|
2025 |
|
2024 |
|||
|
Short-term debt |
|
$ |
— |
|
$ |
1.3 |
|
ABL revolving facility |
|
|
49.5 |
|
|
60.6 |
|
Total debt |
|
|
49.5 |
|
|
61.9 |
|
Less: Cash and cash equivalents |
|
|
13.3 |
|
|
7.1 |
|
Net debt |
|
$ |
36.2 |
|
$ |
54.8 |
|
Net debt is not intended to represent total debt as defined by GAAP. Net debt is utilized by management in evaluating the Company’s financial leverage and equity valuation, and management believes that investors also may find net debt to be helpful for the same purposes.
|
|
Net leverage ratio is a non-GAAP financial measure. It is not intended to represent the stand-alone results for Tredegar under GAAP and should not be considered as an alternative to net income (loss) and total debt as defined by GAAP. Net leverage ratio is utilized by management in evaluating the Company’s financial leverage, and management believes that investors also may find the net leverage ratio to be helpful for the same purposes. In addition, earnings before interest, taxes, depreciation and amortization as defined in the ABL Facility ("Credit EBITDA") is provided below. |
|
|
As of or for Twelve Months Ended |
|
|
($ in millions) |
||
|
Net debt |
$ |
36.2 |
|
Credit EBITDA2 |
$ |
53.2 |
|
Net leverage ratio |
|
0.7 |
|
1. Actual Credit EBITDA amounts are for the twelve months ended |
||
|
2. See Note (h) for more information. |
||
|
(f) |
Tredegar’s presentation of Consolidated EBITDA from ongoing operations is a non-GAAP financial measure that excludes the effects of gains or losses associated with plant shutdowns, asset impairments and restructurings, gains or losses from the sale of assets, goodwill impairment charges, discontinued operations, net periodic benefit cost for the frozen defined benefit pension plan and other items (which includes gains and losses for an investment accounted for under the fair value method). Consolidated EBITDA from ongoing operations also excludes depreciation & amortization, stock option-based compensation costs, interest and income taxes. Consolidated EBITDA is a key financial and analytical measure used by management to gauge the operating performance of Tredegar’s ongoing operations. It is not intended to represent the stand-alone results for Tredegar’s ongoing operations under GAAP and should not be considered as an alternative to net income (loss) or earnings (loss) per share as defined by GAAP. It excludes items that management believes do not relate to Tredegar’s ongoing operations. A reconciliation of Consolidated EBITDA from ongoing operations for the three and nine months ended |
|
|
Three Months Ended
|
|
Nine Months Ended
|
|||||||||
|
($ in millions) |
|
2025 |
|
|
2024 |
|
|
|
2025 |
|
|
2024 |
|
Net income (loss) from continuing operations as reported under GAAP1 |
$ |
7.1 |
|
$ |
(3.4 |
) |
|
$ |
9.6 |
|
$ |
8.4 |
|
After-tax effects of: |
|
|
|
|
|
|
|
|||||
|
(Gains) losses associated with plant shutdowns, asset impairments and restructurings |
|
0.3 |
|
|
— |
|
|
|
0.3 |
|
|
0.5 |
|
Valuation allowance on existing deferred tax assets as a result of the sale of Terphane |
|
— |
|
|
1.8 |
|
|
|
— |
|
|
1.8 |
|
(Gains) losses from sale of assets and other |
|
1.8 |
|
|
1.8 |
|
|
|
4.7 |
|
|
4.6 |
|
Net income (loss) from ongoing operations1 |
|
9.2 |
|
|
0.2 |
|
|
|
14.6 |
|
|
15.3 |
|
Depreciation and amortization |
|
5.5 |
|
|
5.8 |
|
|
|
16.4 |
|
|
17.6 |
|
Interest expense |
|
0.8 |
|
|
1.2 |
|
|
|
3.6 |
|
|
3.5 |
|
Income taxes from ongoing operations1 |
|
2.6 |
|
|
(0.4 |
) |
|
|
5.1 |
|
|
2.9 |
|
Consolidated EBITDA from ongoing operations |
$ |
18.1 |
|
$ |
6.8 |
|
|
$ |
39.7 |
|
$ |
39.3 |
|
1. Reconciliations of the pre-tax and post-tax balances attributed to net income (loss) from continuing operations are shown in Note (d). |
||||||||||||
|
(g) |
In |
|
|
(h) |
The computation of Credit EBITDA, as defined in the ABL Facility, is presented below. |
|
Computations of Credit EBITDA (as defined in the ABL Facility) as of and for the
Twelve Months Ended |
|||
|
Computations of Credit EBITDA for the twelve months ended |
|||
|
Net income (loss) |
$ |
(53,793 |
) |
|
Plus: |
|
||
|
After-tax losses related to discontinued operations |
|
56,062 |
|
|
Total income tax expense for continuing operations |
|
235 |
|
|
Interest expense |
|
4,715 |
|
|
Depreciation and amortization expense for continuing operations |
|
21,996 |
|
|
All non-cash losses and expenses, plus cash losses and expenses not to exceed |
|
23,735 |
|
|
Charges related to stock option grants and awards accounted for under the fair value-based method |
|
— |
|
|
Losses related to the application of the equity method of accounting |
|
— |
|
|
Losses related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting |
|
— |
|
|
Fees, costs and expenses incurred in connection with the amendment process (Amendment No. 3 “ABL Transition”) |
|
289 |
|
|
Fees, costs and expenses incurred in connection with the amendment process (Amendment No. 5) |
|
— |
|
|
Minus: |
|
||
|
After-tax income related to discontinued operations |
|
— |
|
|
Total income tax benefits for continuing operations |
|
— |
|
|
Interest income |
|
(22 |
) |
|
All non-cash gains and income, plus cash gains and income in excess of |
|
— |
|
|
Income related to changes in estimates for stock option grants and awards accounted for under the fair value-based method |
|
— |
|
|
Income related to the application of the equity method of accounting |
|
— |
|
|
Income related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting |
|
— |
|
|
Plus or minus, as applicable, pro forma EBITDA adjustments associated with acquisitions and asset dispositions |
|
— |
|
|
Credit EBITDA |
$ |
53,217 |
|
|
Fixed charge coverage ratio**: |
|
||
|
Credit EBITDA |
$ |
53,217 |
|
|
Unfinanced capital expenditures |
$ |
15,516 |
|
|
Fixed charges |
$ |
5,494 |
|
|
Fixed charge coverage ratio |
|
6.86 |
|
|
* Credit EBITDA is not intended to represent net income (loss) or cash flow from operations as defined by GAAP and should not be considered as an alternative to either net income (loss) or to cash flow. |
|||
|
** Fixed Charge Coverage Ratio is computed as the ratio of (a) Credit EBITDA minus Unfinanced Capital Expenditures to (b) Fixed Charges. |
|||
View source version on businesswire.com: https://www.businesswire.com/news/home/20251106358521/en/
Source: